nodes	percent_of_prediction	percent_of_DWPC	metapath
Verapamil—ABCC3—Ezetimibe—atherosclerosis	0.0431	0.0569	CbGbCtD
Verapamil—ABCB11—Rosuvastatin—atherosclerosis	0.0372	0.0492	CbGbCtD
Verapamil—ABCB11—Pravastatin—atherosclerosis	0.0339	0.0447	CbGbCtD
Verapamil—ABCC4—Rosuvastatin—atherosclerosis	0.0329	0.0434	CbGbCtD
Verapamil—SLC22A5—Niacin—atherosclerosis	0.0296	0.039	CbGbCtD
Verapamil—ABCC1—Rosuvastatin—atherosclerosis	0.0265	0.0349	CbGbCtD
Verapamil—SLCO1A2—Rosuvastatin—atherosclerosis	0.0236	0.0312	CbGbCtD
Verapamil—SLCO1B1—Ezetimibe—atherosclerosis	0.0223	0.0294	CbGbCtD
Verapamil—SLCO1B1—Rosuvastatin—atherosclerosis	0.0223	0.0294	CbGbCtD
Verapamil—SLCO1A2—Simvastatin—atherosclerosis	0.022	0.029	CbGbCtD
Verapamil—SLCO1A2—Lovastatin—atherosclerosis	0.0215	0.0284	CbGbCtD
Verapamil—SLCO1A2—Pravastatin—atherosclerosis	0.0215	0.0284	CbGbCtD
Verapamil—SLCO1B1—Simvastatin—atherosclerosis	0.0207	0.0273	CbGbCtD
Verapamil—SLCO1B1—Lovastatin—atherosclerosis	0.0203	0.0268	CbGbCtD
Verapamil—SLCO1B1—Pravastatin—atherosclerosis	0.0203	0.0268	CbGbCtD
Verapamil—ABCC2—Ezetimibe—atherosclerosis	0.0196	0.0258	CbGbCtD
Verapamil—ABCC2—Simvastatin—atherosclerosis	0.0182	0.024	CbGbCtD
Verapamil—ABCC2—Pravastatin—atherosclerosis	0.0178	0.0235	CbGbCtD
Verapamil—ABCC2—Lovastatin—atherosclerosis	0.0178	0.0235	CbGbCtD
Verapamil—ABCG2—Ezetimibe—atherosclerosis	0.0177	0.0234	CbGbCtD
Verapamil—ABCG2—Rosuvastatin—atherosclerosis	0.0177	0.0234	CbGbCtD
Verapamil—ABCG2—Pravastatin—atherosclerosis	0.0161	0.0213	CbGbCtD
Verapamil—CYP3A7—Simvastatin—atherosclerosis	0.0122	0.016	CbGbCtD
Verapamil—CYP3A7-CYP3A51P—Simvastatin—atherosclerosis	0.0122	0.016	CbGbCtD
Verapamil—CYP3A7—Lovastatin—atherosclerosis	0.0119	0.0157	CbGbCtD
Verapamil—CYP3A7-CYP3A51P—Lovastatin—atherosclerosis	0.0119	0.0157	CbGbCtD
Verapamil—CYP2B6—Simvastatin—atherosclerosis	0.0116	0.0153	CbGbCtD
Verapamil—CYP3A5—Rosuvastatin—atherosclerosis	0.00981	0.0129	CbGbCtD
Verapamil—CYP3A5—Simvastatin—atherosclerosis	0.00912	0.012	CbGbCtD
Verapamil—CYP3A5—Pravastatin—atherosclerosis	0.00892	0.0118	CbGbCtD
Verapamil—CYP3A5—Lovastatin—atherosclerosis	0.00892	0.0118	CbGbCtD
Verapamil—CYP2C8—Simvastatin—atherosclerosis	0.00877	0.0116	CbGbCtD
Verapamil—CYP2C8—Pravastatin—atherosclerosis	0.00858	0.0113	CbGbCtD
Verapamil—CYP2C8—Lovastatin—atherosclerosis	0.00858	0.0113	CbGbCtD
Verapamil—CYP2C19—Rosuvastatin—atherosclerosis	0.00791	0.0104	CbGbCtD
Verapamil—CYP2C19—Simvastatin—atherosclerosis	0.00736	0.00971	CbGbCtD
Verapamil—CYP2C19—Lovastatin—atherosclerosis	0.0072	0.0095	CbGbCtD
Verapamil—CYP2D6—Niacin—atherosclerosis	0.00707	0.00934	CbGbCtD
Verapamil—CYP2C9—Rosuvastatin—atherosclerosis	0.00658	0.00868	CbGbCtD
Verapamil—ABCB1—Ezetimibe—atherosclerosis	0.00638	0.00842	CbGbCtD
Verapamil—CYP2C9—Simvastatin—atherosclerosis	0.00612	0.00807	CbGbCtD
Verapamil—CYP2C9—Lovastatin—atherosclerosis	0.00599	0.0079	CbGbCtD
Verapamil—CYP2C9—Pravastatin—atherosclerosis	0.00599	0.0079	CbGbCtD
Verapamil—ABCB1—Simvastatin—atherosclerosis	0.00594	0.00783	CbGbCtD
Verapamil—ABCB1—Pravastatin—atherosclerosis	0.00581	0.00766	CbGbCtD
Verapamil—ABCB1—Lovastatin—atherosclerosis	0.00581	0.00766	CbGbCtD
Verapamil—CYP2D6—Simvastatin—atherosclerosis	0.00559	0.00738	CbGbCtD
Verapamil—CYP2D6—Lovastatin—atherosclerosis	0.00547	0.00722	CbGbCtD
Verapamil—CYP2D6—Pravastatin—atherosclerosis	0.00547	0.00722	CbGbCtD
Verapamil—CYP3A4—Ezetimibe—atherosclerosis	0.00383	0.00505	CbGbCtD
Verapamil—CYP3A4—Rosuvastatin—atherosclerosis	0.00383	0.00505	CbGbCtD
Verapamil—CYP3A4—Simvastatin—atherosclerosis	0.00356	0.00469	CbGbCtD
Verapamil—CYP3A4—Pravastatin—atherosclerosis	0.00348	0.00459	CbGbCtD
Verapamil—CYP3A4—Lovastatin—atherosclerosis	0.00348	0.00459	CbGbCtD
Verapamil—CACNA1B—connective tissue—atherosclerosis	0.000686	0.0646	CbGeAlD
Verapamil—Orthostatic hypotension—Niacin—atherosclerosis	0.000553	0.00448	CcSEcCtD
Verapamil—Erectile dysfunction—Ezetimibe—atherosclerosis	0.00055	0.00446	CcSEcCtD
Verapamil—CACNA1S—cardiovascular system—atherosclerosis	0.000549	0.0517	CbGeAlD
Verapamil—Abdominal discomfort—Simvastatin—atherosclerosis	0.000546	0.00443	CcSEcCtD
Verapamil—Stevens-Johnson syndrome—Lovastatin—atherosclerosis	0.000538	0.00436	CcSEcCtD
Verapamil—Cramp muscle—Pravastatin—atherosclerosis	0.000537	0.00435	CcSEcCtD
Verapamil—Muscular weakness—Niacin—atherosclerosis	0.000534	0.00433	CcSEcCtD
Verapamil—Upper respiratory tract infection—Simvastatin—atherosclerosis	0.00053	0.00429	CcSEcCtD
Verapamil—Muscular weakness—Pravastatin—atherosclerosis	0.000526	0.00426	CcSEcCtD
Verapamil—Erectile dysfunction—Simvastatin—atherosclerosis	0.000525	0.00425	CcSEcCtD
Verapamil—Influenza—Niacin—atherosclerosis	0.000523	0.00424	CcSEcCtD
Verapamil—Jaundice—Ezetimibe—atherosclerosis	0.000519	0.00421	CcSEcCtD
Verapamil—Influenza—Pravastatin—atherosclerosis	0.000515	0.00417	CcSEcCtD
Verapamil—CACNB1—cardiovascular system—atherosclerosis	0.000512	0.0482	CbGeAlD
Verapamil—Angina pectoris—Niacin—atherosclerosis	0.00051	0.00413	CcSEcCtD
Verapamil—Sinusitis—Lovastatin—atherosclerosis	0.00051	0.00413	CcSEcCtD
Verapamil—Stevens-Johnson syndrome—Simvastatin—atherosclerosis	0.000504	0.00408	CcSEcCtD
Verapamil—Angina pectoris—Pravastatin—atherosclerosis	0.000502	0.00407	CcSEcCtD
Verapamil—Sweating increased—Pravastatin—atherosclerosis	0.000502	0.00407	CcSEcCtD
Verapamil—Sinusitis—Ezetimibe—atherosclerosis	0.0005	0.00405	CcSEcCtD
Verapamil—Jaundice—Simvastatin—atherosclerosis	0.000495	0.00401	CcSEcCtD
Verapamil—Hepatitis—Lovastatin—atherosclerosis	0.000488	0.00395	CcSEcCtD
Verapamil—Erectile dysfunction—Niacin—atherosclerosis	0.000482	0.0039	CcSEcCtD
Verapamil—Upper respiratory tract infection—Pravastatin—atherosclerosis	0.000479	0.00388	CcSEcCtD
Verapamil—Hepatitis—Ezetimibe—atherosclerosis	0.000478	0.00388	CcSEcCtD
Verapamil—Sinusitis—Simvastatin—atherosclerosis	0.000477	0.00386	CcSEcCtD
Verapamil—Pharyngitis—Ezetimibe—atherosclerosis	0.000475	0.00385	CcSEcCtD
Verapamil—Erectile dysfunction—Pravastatin—atherosclerosis	0.000474	0.00384	CcSEcCtD
Verapamil—Oedema peripheral—Ezetimibe—atherosclerosis	0.000471	0.00382	CcSEcCtD
Verapamil—Erythema multiforme—Lovastatin—atherosclerosis	0.000461	0.00374	CcSEcCtD
Verapamil—Angioedema—Rosuvastatin—atherosclerosis	0.000458	0.00371	CcSEcCtD
Verapamil—Hepatitis—Simvastatin—atherosclerosis	0.000456	0.0037	CcSEcCtD
Verapamil—Stevens-Johnson syndrome—Pravastatin—atherosclerosis	0.000455	0.00369	CcSEcCtD
Verapamil—Jaundice—Niacin—atherosclerosis	0.000455	0.00368	CcSEcCtD
Verapamil—Acute coronary syndrome—Pravastatin—atherosclerosis	0.000453	0.00367	CcSEcCtD
Verapamil—Flushing—Lovastatin—atherosclerosis	0.000453	0.00367	CcSEcCtD
Verapamil—Erythema multiforme—Ezetimibe—atherosclerosis	0.000452	0.00366	CcSEcCtD
Verapamil—CACNB1—adipose tissue—atherosclerosis	0.000451	0.0425	CbGeAlD
Verapamil—Myocardial infarction—Pravastatin—atherosclerosis	0.00045	0.00365	CcSEcCtD
Verapamil—Jaundice—Pravastatin—atherosclerosis	0.000448	0.00363	CcSEcCtD
Verapamil—Sweating—Niacin—atherosclerosis	0.000447	0.00362	CcSEcCtD
Verapamil—Flushing—Ezetimibe—atherosclerosis	0.000444	0.0036	CcSEcCtD
Verapamil—CACNB3—adipose tissue—atherosclerosis	0.000433	0.0407	CbGeAlD
Verapamil—Erythema multiforme—Simvastatin—atherosclerosis	0.000431	0.00349	CcSEcCtD
Verapamil—Sinusitis—Pravastatin—atherosclerosis	0.000431	0.00349	CcSEcCtD
Verapamil—Alopecia—Lovastatin—atherosclerosis	0.000431	0.00349	CcSEcCtD
Verapamil—Myalgia—Rosuvastatin—atherosclerosis	0.000426	0.00346	CcSEcCtD
Verapamil—Arthralgia—Rosuvastatin—atherosclerosis	0.000426	0.00346	CcSEcCtD
Verapamil—Flushing—Simvastatin—atherosclerosis	0.000423	0.00343	CcSEcCtD
Verapamil—Alopecia—Ezetimibe—atherosclerosis	0.000423	0.00342	CcSEcCtD
Verapamil—Rhinitis—Niacin—atherosclerosis	0.00042	0.0034	CcSEcCtD
Verapamil—Hepatitis—Niacin—atherosclerosis	0.000419	0.00339	CcSEcCtD
Verapamil—Hypoaesthesia—Niacin—atherosclerosis	0.000417	0.00338	CcSEcCtD
Verapamil—Rhinitis—Pravastatin—atherosclerosis	0.000413	0.00335	CcSEcCtD
Verapamil—Oedema peripheral—Niacin—atherosclerosis	0.000413	0.00334	CcSEcCtD
Verapamil—Hepatitis—Pravastatin—atherosclerosis	0.000412	0.00334	CcSEcCtD
Verapamil—Confusional state—Rosuvastatin—atherosclerosis	0.000412	0.00334	CcSEcCtD
Verapamil—Hypoaesthesia—Pravastatin—atherosclerosis	0.00041	0.00332	CcSEcCtD
Verapamil—Pharyngitis—Pravastatin—atherosclerosis	0.000409	0.00332	CcSEcCtD
Verapamil—Muscle spasms—Lovastatin—atherosclerosis	0.000408	0.00331	CcSEcCtD
Verapamil—Infection—Rosuvastatin—atherosclerosis	0.000406	0.00329	CcSEcCtD
Verapamil—Visual impairment—Niacin—atherosclerosis	0.000404	0.00327	CcSEcCtD
Verapamil—Alopecia—Simvastatin—atherosclerosis	0.000403	0.00327	CcSEcCtD
Verapamil—Muscle spasms—Ezetimibe—atherosclerosis	0.0004	0.00324	CcSEcCtD
Verapamil—Vision blurred—Lovastatin—atherosclerosis	0.0004	0.00324	CcSEcCtD
Verapamil—Tremor—Lovastatin—atherosclerosis	0.000398	0.00322	CcSEcCtD
Verapamil—Visual impairment—Pravastatin—atherosclerosis	0.000397	0.00322	CcSEcCtD
Verapamil—Tinnitus—Niacin—atherosclerosis	0.00039	0.00316	CcSEcCtD
Verapamil—Erythema multiforme—Pravastatin—atherosclerosis	0.00039	0.00316	CcSEcCtD
Verapamil—Flushing—Niacin—atherosclerosis	0.000389	0.00315	CcSEcCtD
Verapamil—Angioedema—Lovastatin—atherosclerosis	0.000388	0.00314	CcSEcCtD
Verapamil—Tinnitus—Pravastatin—atherosclerosis	0.000384	0.00312	CcSEcCtD
Verapamil—Flushing—Pravastatin—atherosclerosis	0.000383	0.0031	CcSEcCtD
Verapamil—Muscle spasms—Simvastatin—atherosclerosis	0.000382	0.00309	CcSEcCtD
Verapamil—Vertigo—Lovastatin—atherosclerosis	0.000381	0.00309	CcSEcCtD
Verapamil—Angioedema—Ezetimibe—atherosclerosis	0.00038	0.00308	CcSEcCtD
Verapamil—Vision blurred—Simvastatin—atherosclerosis	0.000374	0.00303	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000372	0.00302	CcSEcCtD
Verapamil—Tremor—Simvastatin—atherosclerosis	0.000372	0.00301	CcSEcCtD
Verapamil—Alopecia—Niacin—atherosclerosis	0.00037	0.003	CcSEcCtD
Verapamil—Insomnia—Rosuvastatin—atherosclerosis	0.00037	0.003	CcSEcCtD
Verapamil—Palpitations—Ezetimibe—atherosclerosis	0.000368	0.00298	CcSEcCtD
Verapamil—Paraesthesia—Rosuvastatin—atherosclerosis	0.000367	0.00297	CcSEcCtD
Verapamil—Alopecia—Pravastatin—atherosclerosis	0.000364	0.00295	CcSEcCtD
Verapamil—Angioedema—Simvastatin—atherosclerosis	0.000363	0.00294	CcSEcCtD
Verapamil—Chest pain—Lovastatin—atherosclerosis	0.000361	0.00293	CcSEcCtD
Verapamil—Myalgia—Lovastatin—atherosclerosis	0.000361	0.00293	CcSEcCtD
Verapamil—Arthralgia—Lovastatin—atherosclerosis	0.000361	0.00293	CcSEcCtD
Verapamil—Dyspepsia—Rosuvastatin—atherosclerosis	0.00036	0.00292	CcSEcCtD
Verapamil—Hypertension—Ezetimibe—atherosclerosis	0.000359	0.00291	CcSEcCtD
Verapamil—Discomfort—Lovastatin—atherosclerosis	0.000357	0.00289	CcSEcCtD
Verapamil—Vertigo—Simvastatin—atherosclerosis	0.000357	0.00289	CcSEcCtD
Verapamil—Myalgia—Ezetimibe—atherosclerosis	0.000354	0.00287	CcSEcCtD
Verapamil—Arthralgia—Ezetimibe—atherosclerosis	0.000354	0.00287	CcSEcCtD
Verapamil—Chest pain—Ezetimibe—atherosclerosis	0.000354	0.00287	CcSEcCtD
Verapamil—Dry mouth—Lovastatin—atherosclerosis	0.000353	0.00286	CcSEcCtD
Verapamil—Muscle spasms—Niacin—atherosclerosis	0.00035	0.00284	CcSEcCtD
Verapamil—Discomfort—Ezetimibe—atherosclerosis	0.00035	0.00284	CcSEcCtD
Verapamil—Pain—Rosuvastatin—atherosclerosis	0.00035	0.00283	CcSEcCtD
Verapamil—Constipation—Rosuvastatin—atherosclerosis	0.00035	0.00283	CcSEcCtD
Verapamil—CACNA1H—cardiovascular system—atherosclerosis	0.000349	0.0329	CbGeAlD
Verapamil—Confusional state—Lovastatin—atherosclerosis	0.000349	0.00283	CcSEcCtD
Verapamil—Dry mouth—Ezetimibe—atherosclerosis	0.000347	0.00281	CcSEcCtD
Verapamil—Anaphylactic shock—Lovastatin—atherosclerosis	0.000346	0.00281	CcSEcCtD
Verapamil—Muscle spasms—Pravastatin—atherosclerosis	0.000345	0.0028	CcSEcCtD
Verapamil—Infection—Lovastatin—atherosclerosis	0.000344	0.00279	CcSEcCtD
Verapamil—Vision blurred—Niacin—atherosclerosis	0.000344	0.00278	CcSEcCtD
Verapamil—Confusional state—Ezetimibe—atherosclerosis	0.000343	0.00278	CcSEcCtD
Verapamil—Anaphylactic shock—Ezetimibe—atherosclerosis	0.00034	0.00275	CcSEcCtD
Verapamil—Vision blurred—Pravastatin—atherosclerosis	0.000338	0.00274	CcSEcCtD
Verapamil—Chest pain—Simvastatin—atherosclerosis	0.000338	0.00274	CcSEcCtD
Verapamil—Myalgia—Simvastatin—atherosclerosis	0.000338	0.00274	CcSEcCtD
Verapamil—Arthralgia—Simvastatin—atherosclerosis	0.000338	0.00274	CcSEcCtD
Verapamil—Infection—Ezetimibe—atherosclerosis	0.000338	0.00274	CcSEcCtD
Verapamil—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000337	0.00273	CcSEcCtD
Verapamil—Tremor—Pravastatin—atherosclerosis	0.000336	0.00272	CcSEcCtD
Verapamil—Discomfort—Simvastatin—atherosclerosis	0.000334	0.00271	CcSEcCtD
Verapamil—Angioedema—Niacin—atherosclerosis	0.000333	0.0027	CcSEcCtD
Verapamil—CACNB2—cardiovascular system—atherosclerosis	0.00033	0.031	CbGeAlD
Verapamil—Angioedema—Pravastatin—atherosclerosis	0.000328	0.00266	CcSEcCtD
Verapamil—Vertigo—Niacin—atherosclerosis	0.000328	0.00265	CcSEcCtD
Verapamil—Syncope—Niacin—atherosclerosis	0.000327	0.00265	CcSEcCtD
Verapamil—Confusional state—Simvastatin—atherosclerosis	0.000327	0.00265	CcSEcCtD
Verapamil—Urticaria—Rosuvastatin—atherosclerosis	0.000325	0.00263	CcSEcCtD
Verapamil—Anaphylactic shock—Simvastatin—atherosclerosis	0.000324	0.00263	CcSEcCtD
Verapamil—Oedema—Simvastatin—atherosclerosis	0.000324	0.00263	CcSEcCtD
Verapamil—Vertigo—Pravastatin—atherosclerosis	0.000322	0.00261	CcSEcCtD
Verapamil—Palpitations—Niacin—atherosclerosis	0.000322	0.00261	CcSEcCtD
Verapamil—Infection—Simvastatin—atherosclerosis	0.000322	0.00261	CcSEcCtD
Verapamil—Loss of consciousness—Niacin—atherosclerosis	0.00032	0.0026	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000316	0.00256	CcSEcCtD
Verapamil—Insomnia—Lovastatin—atherosclerosis	0.000313	0.00254	CcSEcCtD
Verapamil—KCNJ11—cardiovascular system—atherosclerosis	0.000313	0.0295	CbGeAlD
Verapamil—Paraesthesia—Lovastatin—atherosclerosis	0.000311	0.00252	CcSEcCtD
Verapamil—Myalgia—Niacin—atherosclerosis	0.00031	0.00251	CcSEcCtD
Verapamil—Arthralgia—Niacin—atherosclerosis	0.00031	0.00251	CcSEcCtD
Verapamil—Hypertension—Pravastatin—atherosclerosis	0.00031	0.00251	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.00031	0.00251	CcSEcCtD
Verapamil—Dyspnoea—Lovastatin—atherosclerosis	0.000309	0.0025	CcSEcCtD
Verapamil—Insomnia—Ezetimibe—atherosclerosis	0.000307	0.00249	CcSEcCtD
Verapamil—CACNA1C—connective tissue—atherosclerosis	0.000306	0.0288	CbGeAlD
Verapamil—Arthralgia—Pravastatin—atherosclerosis	0.000306	0.00248	CcSEcCtD
Verapamil—Chest pain—Pravastatin—atherosclerosis	0.000306	0.00248	CcSEcCtD
Verapamil—Myalgia—Pravastatin—atherosclerosis	0.000306	0.00248	CcSEcCtD
Verapamil—Paraesthesia—Ezetimibe—atherosclerosis	0.000305	0.00247	CcSEcCtD
Verapamil—Dyspepsia—Lovastatin—atherosclerosis	0.000305	0.00247	CcSEcCtD
Verapamil—Dry mouth—Niacin—atherosclerosis	0.000304	0.00246	CcSEcCtD
Verapamil—Dyspnoea—Ezetimibe—atherosclerosis	0.000303	0.00245	CcSEcCtD
Verapamil—Discomfort—Pravastatin—atherosclerosis	0.000302	0.00245	CcSEcCtD
Verapamil—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000301	0.00244	CcSEcCtD
Verapamil—Dyspepsia—Ezetimibe—atherosclerosis	0.000299	0.00242	CcSEcCtD
Verapamil—Fatigue—Lovastatin—atherosclerosis	0.000299	0.00242	CcSEcCtD
Verapamil—Oedema—Niacin—atherosclerosis	0.000298	0.00241	CcSEcCtD
Verapamil—Anaphylactic shock—Niacin—atherosclerosis	0.000298	0.00241	CcSEcCtD
Verapamil—Constipation—Lovastatin—atherosclerosis	0.000296	0.0024	CcSEcCtD
Verapamil—Pain—Lovastatin—atherosclerosis	0.000296	0.0024	CcSEcCtD
Verapamil—Confusional state—Pravastatin—atherosclerosis	0.000295	0.00239	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000295	0.00239	CcSEcCtD
Verapamil—Asthenia—Rosuvastatin—atherosclerosis	0.000293	0.00238	CcSEcCtD
Verapamil—Insomnia—Simvastatin—atherosclerosis	0.000293	0.00237	CcSEcCtD
Verapamil—Anaphylactic shock—Pravastatin—atherosclerosis	0.000293	0.00237	CcSEcCtD
Verapamil—Oedema—Pravastatin—atherosclerosis	0.000293	0.00237	CcSEcCtD
Verapamil—Fatigue—Ezetimibe—atherosclerosis	0.000293	0.00237	CcSEcCtD
Verapamil—Shock—Niacin—atherosclerosis	0.000293	0.00237	CcSEcCtD
Verapamil—Infection—Pravastatin—atherosclerosis	0.000291	0.00236	CcSEcCtD
Verapamil—Paraesthesia—Simvastatin—atherosclerosis	0.000291	0.00236	CcSEcCtD
Verapamil—Pain—Ezetimibe—atherosclerosis	0.000291	0.00235	CcSEcCtD
Verapamil—Constipation—Ezetimibe—atherosclerosis	0.000291	0.00235	CcSEcCtD
Verapamil—Tachycardia—Niacin—atherosclerosis	0.00029	0.00235	CcSEcCtD
Verapamil—Pruritus—Rosuvastatin—atherosclerosis	0.000289	0.00234	CcSEcCtD
Verapamil—Dyspnoea—Simvastatin—atherosclerosis	0.000289	0.00234	CcSEcCtD
Verapamil—CACNA1D—cardiovascular system—atherosclerosis	0.000288	0.0271	CbGeAlD
Verapamil—Hyperhidrosis—Niacin—atherosclerosis	0.000288	0.00233	CcSEcCtD
Verapamil—Feeling abnormal—Lovastatin—atherosclerosis	0.000285	0.00231	CcSEcCtD
Verapamil—Dyspepsia—Simvastatin—atherosclerosis	0.000285	0.00231	CcSEcCtD
Verapamil—Hyperhidrosis—Pravastatin—atherosclerosis	0.000283	0.00229	CcSEcCtD
Verapamil—Feeling abnormal—Ezetimibe—atherosclerosis	0.00028	0.00227	CcSEcCtD
Verapamil—Diarrhoea—Rosuvastatin—atherosclerosis	0.00028	0.00227	CcSEcCtD
Verapamil—Fatigue—Simvastatin—atherosclerosis	0.000279	0.00226	CcSEcCtD
Verapamil—Hypotension—Niacin—atherosclerosis	0.000278	0.00225	CcSEcCtD
Verapamil—Pain—Simvastatin—atherosclerosis	0.000277	0.00225	CcSEcCtD
Verapamil—Constipation—Simvastatin—atherosclerosis	0.000277	0.00225	CcSEcCtD
Verapamil—Urticaria—Lovastatin—atherosclerosis	0.000275	0.00223	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000271	0.0022	CcSEcCtD
Verapamil—Dizziness—Rosuvastatin—atherosclerosis	0.00027	0.00219	CcSEcCtD
Verapamil—Urticaria—Ezetimibe—atherosclerosis	0.00027	0.00219	CcSEcCtD
Verapamil—Insomnia—Niacin—atherosclerosis	0.000269	0.00218	CcSEcCtD
Verapamil—Paraesthesia—Niacin—atherosclerosis	0.000267	0.00216	CcSEcCtD
Verapamil—Feeling abnormal—Simvastatin—atherosclerosis	0.000267	0.00216	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000267	0.00216	CcSEcCtD
Verapamil—CACNA1C—cardiovascular system—atherosclerosis	0.000266	0.025	CbGeAlD
Verapamil—Dyspnoea—Niacin—atherosclerosis	0.000265	0.00215	CcSEcCtD
Verapamil—Insomnia—Pravastatin—atherosclerosis	0.000265	0.00215	CcSEcCtD
Verapamil—Somnolence—Niacin—atherosclerosis	0.000264	0.00214	CcSEcCtD
Verapamil—Paraesthesia—Pravastatin—atherosclerosis	0.000263	0.00213	CcSEcCtD
Verapamil—Dyspepsia—Niacin—atherosclerosis	0.000262	0.00212	CcSEcCtD
Verapamil—Dyspnoea—Pravastatin—atherosclerosis	0.000261	0.00212	CcSEcCtD
Verapamil—SCN5A—cardiovascular system—atherosclerosis	0.000258	0.0243	CbGeAlD
Verapamil—Dyspepsia—Pravastatin—atherosclerosis	0.000258	0.00209	CcSEcCtD
Verapamil—Rash—Rosuvastatin—atherosclerosis	0.000258	0.00209	CcSEcCtD
Verapamil—Dermatitis—Rosuvastatin—atherosclerosis	0.000257	0.00209	CcSEcCtD
Verapamil—Urticaria—Simvastatin—atherosclerosis	0.000257	0.00209	CcSEcCtD
Verapamil—Headache—Rosuvastatin—atherosclerosis	0.000256	0.00207	CcSEcCtD
Verapamil—Hypersensitivity—Lovastatin—atherosclerosis	0.000255	0.00207	CcSEcCtD
Verapamil—Pain—Niacin—atherosclerosis	0.000254	0.00206	CcSEcCtD
Verapamil—Fatigue—Pravastatin—atherosclerosis	0.000253	0.00205	CcSEcCtD
Verapamil—Constipation—Pravastatin—atherosclerosis	0.000251	0.00203	CcSEcCtD
Verapamil—Pain—Pravastatin—atherosclerosis	0.000251	0.00203	CcSEcCtD
Verapamil—Hypersensitivity—Ezetimibe—atherosclerosis	0.00025	0.00203	CcSEcCtD
Verapamil—Asthenia—Lovastatin—atherosclerosis	0.000249	0.00201	CcSEcCtD
Verapamil—Pruritus—Lovastatin—atherosclerosis	0.000245	0.00199	CcSEcCtD
Verapamil—Asthenia—Ezetimibe—atherosclerosis	0.000244	0.00198	CcSEcCtD
Verapamil—Nausea—Rosuvastatin—atherosclerosis	0.000243	0.00197	CcSEcCtD
Verapamil—CYP2C18—liver—atherosclerosis	0.000242	0.0228	CbGeAlD
Verapamil—Feeling abnormal—Pravastatin—atherosclerosis	0.000241	0.00196	CcSEcCtD
Verapamil—Pruritus—Ezetimibe—atherosclerosis	0.00024	0.00195	CcSEcCtD
Verapamil—Hypersensitivity—Simvastatin—atherosclerosis	0.000239	0.00193	CcSEcCtD
Verapamil—Diarrhoea—Lovastatin—atherosclerosis	0.000237	0.00192	CcSEcCtD
Verapamil—Urticaria—Niacin—atherosclerosis	0.000236	0.00192	CcSEcCtD
Verapamil—ABCB11—liver—atherosclerosis	0.000235	0.0221	CbGeAlD
Verapamil—CACNA1C—adipose tissue—atherosclerosis	0.000235	0.0221	CbGeAlD
Verapamil—Urticaria—Pravastatin—atherosclerosis	0.000233	0.00189	CcSEcCtD
Verapamil—Asthenia—Simvastatin—atherosclerosis	0.000232	0.00188	CcSEcCtD
Verapamil—Diarrhoea—Ezetimibe—atherosclerosis	0.000232	0.00188	CcSEcCtD
Verapamil—CYP3A7—liver—atherosclerosis	0.00023	0.0217	CbGeAlD
Verapamil—Pruritus—Simvastatin—atherosclerosis	0.000229	0.00186	CcSEcCtD
Verapamil—Dizziness—Lovastatin—atherosclerosis	0.000229	0.00186	CcSEcCtD
Verapamil—Dizziness—Ezetimibe—atherosclerosis	0.000225	0.00182	CcSEcCtD
Verapamil—Diarrhoea—Simvastatin—atherosclerosis	0.000222	0.0018	CcSEcCtD
Verapamil—Vomiting—Lovastatin—atherosclerosis	0.00022	0.00178	CcSEcCtD
Verapamil—Hypersensitivity—Niacin—atherosclerosis	0.000219	0.00178	CcSEcCtD
Verapamil—Rash—Lovastatin—atherosclerosis	0.000218	0.00177	CcSEcCtD
Verapamil—Dermatitis—Lovastatin—atherosclerosis	0.000218	0.00177	CcSEcCtD
Verapamil—Headache—Lovastatin—atherosclerosis	0.000217	0.00176	CcSEcCtD
Verapamil—Vomiting—Ezetimibe—atherosclerosis	0.000216	0.00175	CcSEcCtD
Verapamil—CACNA1H—liver—atherosclerosis	0.000216	0.0203	CbGeAlD
Verapamil—Hypersensitivity—Pravastatin—atherosclerosis	0.000216	0.00175	CcSEcCtD
Verapamil—Dizziness—Simvastatin—atherosclerosis	0.000214	0.00174	CcSEcCtD
Verapamil—Rash—Ezetimibe—atherosclerosis	0.000214	0.00174	CcSEcCtD
Verapamil—Dermatitis—Ezetimibe—atherosclerosis	0.000214	0.00173	CcSEcCtD
Verapamil—ABCC3—adipose tissue—atherosclerosis	0.000214	0.0201	CbGeAlD
Verapamil—Asthenia—Niacin—atherosclerosis	0.000213	0.00173	CcSEcCtD
Verapamil—Headache—Ezetimibe—atherosclerosis	0.000213	0.00172	CcSEcCtD
Verapamil—ABCC10—adipose tissue—atherosclerosis	0.000212	0.02	CbGeAlD
Verapamil—Pruritus—Niacin—atherosclerosis	0.00021	0.00171	CcSEcCtD
Verapamil—Asthenia—Pravastatin—atherosclerosis	0.00021	0.0017	CcSEcCtD
Verapamil—Pruritus—Pravastatin—atherosclerosis	0.000207	0.00168	CcSEcCtD
Verapamil—Vomiting—Simvastatin—atherosclerosis	0.000206	0.00167	CcSEcCtD
Verapamil—Nausea—Lovastatin—atherosclerosis	0.000206	0.00167	CcSEcCtD
Verapamil—Rash—Simvastatin—atherosclerosis	0.000204	0.00166	CcSEcCtD
Verapamil—Dermatitis—Simvastatin—atherosclerosis	0.000204	0.00165	CcSEcCtD
Verapamil—CACNB2—liver—atherosclerosis	0.000204	0.0192	CbGeAlD
Verapamil—Diarrhoea—Niacin—atherosclerosis	0.000204	0.00165	CcSEcCtD
Verapamil—Headache—Simvastatin—atherosclerosis	0.000203	0.00164	CcSEcCtD
Verapamil—Nausea—Ezetimibe—atherosclerosis	0.000202	0.00164	CcSEcCtD
Verapamil—Diarrhoea—Pravastatin—atherosclerosis	0.0002	0.00162	CcSEcCtD
Verapamil—SLC22A4—adipose tissue—atherosclerosis	0.0002	0.0188	CbGeAlD
Verapamil—Dizziness—Niacin—atherosclerosis	0.000197	0.00159	CcSEcCtD
Verapamil—CYP3A7-CYP3A51P—liver—atherosclerosis	0.000196	0.0184	CbGeAlD
Verapamil—Dizziness—Pravastatin—atherosclerosis	0.000194	0.00157	CcSEcCtD
Verapamil—Nausea—Simvastatin—atherosclerosis	0.000192	0.00156	CcSEcCtD
Verapamil—SLC22A1—adipose tissue—atherosclerosis	0.00019	0.0179	CbGeAlD
Verapamil—Vomiting—Niacin—atherosclerosis	0.000189	0.00153	CcSEcCtD
Verapamil—Rash—Niacin—atherosclerosis	0.000188	0.00152	CcSEcCtD
Verapamil—Dermatitis—Niacin—atherosclerosis	0.000187	0.00152	CcSEcCtD
Verapamil—Headache—Niacin—atherosclerosis	0.000186	0.00151	CcSEcCtD
Verapamil—Vomiting—Pravastatin—atherosclerosis	0.000186	0.00151	CcSEcCtD
Verapamil—Rash—Pravastatin—atherosclerosis	0.000185	0.0015	CcSEcCtD
Verapamil—Dermatitis—Pravastatin—atherosclerosis	0.000185	0.0015	CcSEcCtD
Verapamil—Headache—Pravastatin—atherosclerosis	0.000184	0.00149	CcSEcCtD
Verapamil—CACNA1D—liver—atherosclerosis	0.000178	0.0168	CbGeAlD
Verapamil—Nausea—Niacin—atherosclerosis	0.000177	0.00143	CcSEcCtD
Verapamil—ABCC4—adipose tissue—atherosclerosis	0.000176	0.0166	CbGeAlD
Verapamil—Nausea—Pravastatin—atherosclerosis	0.000174	0.00141	CcSEcCtD
Verapamil—KCNH2—cardiovascular system—atherosclerosis	0.000159	0.0149	CbGeAlD
Verapamil—SLCO1B1—liver—atherosclerosis	0.000158	0.0149	CbGeAlD
Verapamil—ABCB1—blood vessel—atherosclerosis	0.000156	0.0147	CbGeAlD
Verapamil—ABCC1—adipose tissue—atherosclerosis	0.00015	0.0141	CbGeAlD
Verapamil—ABCC3—liver—atherosclerosis	0.00015	0.0141	CbGeAlD
Verapamil—ABCC10—liver—atherosclerosis	0.000149	0.014	CbGeAlD
Verapamil—SLC22A1—liver—atherosclerosis	0.000133	0.0126	CbGeAlD
Verapamil—SLC22A5—adipose tissue—atherosclerosis	0.000132	0.0124	CbGeAlD
Verapamil—CYP2B6—cardiovascular system—atherosclerosis	0.00013	0.0122	CbGeAlD
Verapamil—CYP2C9—cardiovascular system—atherosclerosis	0.000129	0.0121	CbGeAlD
Verapamil—SLCO1A2—liver—atherosclerosis	0.000128	0.0121	CbGeAlD
Verapamil—ABCG2—adipose tissue—atherosclerosis	0.000124	0.0117	CbGeAlD
Verapamil—ABCC4—liver—atherosclerosis	0.000124	0.0116	CbGeAlD
Verapamil—ABCC2—liver—atherosclerosis	0.00012	0.0113	CbGeAlD
Verapamil—CYP3A5—adipose tissue—atherosclerosis	0.000115	0.0109	CbGeAlD
Verapamil—ABCC1—liver—atherosclerosis	0.000105	0.00992	CbGeAlD
Verapamil—CYP2C19—liver—atherosclerosis	0.000103	0.00968	CbGeAlD
Verapamil—SLC22A5—liver—atherosclerosis	9.27e-05	0.00872	CbGeAlD
Verapamil—CYP2C8—liver—atherosclerosis	8.97e-05	0.00844	CbGeAlD
Verapamil—ABCG2—liver—atherosclerosis	8.72e-05	0.00821	CbGeAlD
Verapamil—CYP1A2—liver—atherosclerosis	8.4e-05	0.0079	CbGeAlD
Verapamil—CYP3A5—liver—atherosclerosis	8.1e-05	0.00762	CbGeAlD
Verapamil—CYP2B6—liver—atherosclerosis	8.05e-05	0.00757	CbGeAlD
Verapamil—CYP2C9—liver—atherosclerosis	7.97e-05	0.0075	CbGeAlD
Verapamil—ABCB1—cardiovascular system—atherosclerosis	6.96e-05	0.00655	CbGeAlD
Verapamil—ABCB1—adipose tissue—atherosclerosis	6.13e-05	0.00577	CbGeAlD
Verapamil—CYP3A4—liver—atherosclerosis	6.08e-05	0.00572	CbGeAlD
Verapamil—CYP2D6—liver—atherosclerosis	5.98e-05	0.00563	CbGeAlD
Verapamil—ABCB1—liver—atherosclerosis	4.3e-05	0.00405	CbGeAlD
Verapamil—ABCG2—Metabolism—PIK3CG—atherosclerosis	3.85e-06	3.56e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—APOB—atherosclerosis	3.82e-06	3.53e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—PIK3CG—atherosclerosis	3.81e-06	3.52e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—GSTM1—atherosclerosis	3.8e-06	3.51e-05	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—ALB—atherosclerosis	3.79e-06	3.51e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	3.79e-06	3.5e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	3.73e-06	3.45e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—LPL—atherosclerosis	3.73e-06	3.45e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—PPARG—atherosclerosis	3.71e-06	3.43e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—GSTM1—atherosclerosis	3.71e-06	3.43e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—HMGCR—atherosclerosis	3.7e-06	3.42e-05	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—PTGS2—atherosclerosis	3.69e-06	3.41e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—PPARG—atherosclerosis	3.68e-06	3.4e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—HMGCR—atherosclerosis	3.67e-06	3.39e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	3.66e-06	3.39e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	3.66e-06	3.39e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—APOA2—atherosclerosis	3.66e-06	3.39e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—ALOX15—atherosclerosis	3.66e-06	3.39e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—LPL—atherosclerosis	3.64e-06	3.37e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—INS—atherosclerosis	3.64e-06	3.37e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—GPX1—atherosclerosis	3.64e-06	3.36e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	3.63e-06	3.36e-05	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—NOS3—atherosclerosis	3.63e-06	3.35e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—NAMPT—atherosclerosis	3.62e-06	3.35e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—ABCG5—atherosclerosis	3.62e-06	3.34e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—INS—atherosclerosis	3.61e-06	3.34e-05	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—ALB—atherosclerosis	3.6e-06	3.33e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	3.6e-06	3.33e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—LIPC—atherosclerosis	3.6e-06	3.32e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—ABCA1—atherosclerosis	3.59e-06	3.32e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—APOC3—atherosclerosis	3.57e-06	3.3e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—GPX1—atherosclerosis	3.55e-06	3.29e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—LDLR—atherosclerosis	3.55e-06	3.28e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—PIK3CG—atherosclerosis	3.55e-06	3.28e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—CD36—atherosclerosis	3.54e-06	3.27e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—ABCA1—atherosclerosis	3.5e-06	3.24e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—LPA—atherosclerosis	3.49e-06	3.23e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—CETP—atherosclerosis	3.47e-06	3.21e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—CD36—atherosclerosis	3.46e-06	3.2e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—HMOX1—atherosclerosis	3.45e-06	3.19e-05	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—NOS3—atherosclerosis	3.45e-06	3.19e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—PPARG—atherosclerosis	3.42e-06	3.17e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—BGN—atherosclerosis	3.38e-06	3.13e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—INS—atherosclerosis	3.36e-06	3.1e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—MTHFR—atherosclerosis	3.36e-06	3.1e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—APOA5—atherosclerosis	3.35e-06	3.1e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—ALB—atherosclerosis	3.34e-06	3.09e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—SCARB1—atherosclerosis	3.32e-06	3.07e-05	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—PTGS2—atherosclerosis	3.32e-06	3.07e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	3.31e-06	3.06e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—ALB—atherosclerosis	3.31e-06	3.06e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—APOB—atherosclerosis	3.3e-06	3.06e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—ABCA1—atherosclerosis	3.3e-06	3.05e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—PPARA—atherosclerosis	3.29e-06	3.04e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—MTHFR—atherosclerosis	3.28e-06	3.03e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—ABCA1—atherosclerosis	3.27e-06	3.03e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	3.23e-06	2.99e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	3.22e-06	2.98e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—PPARA—atherosclerosis	3.22e-06	2.97e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—GSTM1—atherosclerosis	3.21e-06	2.97e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—NOS3—atherosclerosis	3.19e-06	2.95e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—AGT—atherosclerosis	3.19e-06	2.95e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—NOS3—atherosclerosis	3.16e-06	2.93e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—LPL—atherosclerosis	3.16e-06	2.92e-05	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—PTGS2—atherosclerosis	3.15e-06	2.92e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—HMGCR—atherosclerosis	3.14e-06	2.9e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—APOE—atherosclerosis	3.12e-06	2.89e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—AGT—atherosclerosis	3.12e-06	2.88e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—ALOX5—atherosclerosis	3.11e-06	2.88e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—CAV1—atherosclerosis	3.1e-06	2.86e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—STAT3—atherosclerosis	3.09e-06	2.86e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—APOA1—atherosclerosis	3.09e-06	2.86e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—HMOX1—atherosclerosis	3.08e-06	2.85e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—ALB—atherosclerosis	3.08e-06	2.85e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—GPX1—atherosclerosis	3.08e-06	2.85e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—APOE—atherosclerosis	3.05e-06	2.82e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—CAV1—atherosclerosis	3.03e-06	2.8e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—APOA1—atherosclerosis	3.02e-06	2.79e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—HMOX1—atherosclerosis	3.01e-06	2.78e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—CD36—atherosclerosis	3e-06	2.77e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—MAPK3—atherosclerosis	2.95e-06	2.73e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—APOB—atherosclerosis	2.95e-06	2.73e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—NOS3—atherosclerosis	2.95e-06	2.72e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—PTGS2—atherosclerosis	2.92e-06	2.7e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—PTGS2—atherosclerosis	2.89e-06	2.68e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—APOB—atherosclerosis	2.88e-06	2.66e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—GSTM1—atherosclerosis	2.87e-06	2.65e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—TGFB1—atherosclerosis	2.86e-06	2.65e-05	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—AKT1—atherosclerosis	2.85e-06	2.64e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—MTHFR—atherosclerosis	2.84e-06	2.63e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—HMOX1—atherosclerosis	2.83e-06	2.62e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	2.83e-06	2.62e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—PIK3CG—atherosclerosis	2.82e-06	2.61e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—LPL—atherosclerosis	2.82e-06	2.6e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—HMOX1—atherosclerosis	2.81e-06	2.6e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—GSTM1—atherosclerosis	2.8e-06	2.59e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—ABCA1—atherosclerosis	2.8e-06	2.59e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—NAMPT—atherosclerosis	2.79e-06	2.58e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—PPARA—atherosclerosis	2.79e-06	2.58e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—LIPC—atherosclerosis	2.78e-06	2.57e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—APOC3—atherosclerosis	2.76e-06	2.55e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—PIK3CG—atherosclerosis	2.76e-06	2.55e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—LPL—atherosclerosis	2.75e-06	2.54e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—GPX1—atherosclerosis	2.75e-06	2.54e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—LDLR—atherosclerosis	2.74e-06	2.53e-05	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—AKT1—atherosclerosis	2.72e-06	2.52e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—PPARG—atherosclerosis	2.72e-06	2.52e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—APOB—atherosclerosis	2.71e-06	2.51e-05	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—AKT1—atherosclerosis	2.7e-06	2.5e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—AGT—atherosclerosis	2.7e-06	2.5e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—PTGS2—atherosclerosis	2.69e-06	2.49e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—APOB—atherosclerosis	2.69e-06	2.49e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—GPX1—atherosclerosis	2.68e-06	2.48e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—CETP—atherosclerosis	2.68e-06	2.48e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—CD36—atherosclerosis	2.68e-06	2.47e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—INS—atherosclerosis	2.67e-06	2.47e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—PPARG—atherosclerosis	2.66e-06	2.46e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—APOE—atherosclerosis	2.64e-06	2.45e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—GSTM1—atherosclerosis	2.64e-06	2.44e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—CAV1—atherosclerosis	2.62e-06	2.42e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—GSTM1—atherosclerosis	2.62e-06	2.42e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—APOA1—atherosclerosis	2.61e-06	2.42e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—CD36—atherosclerosis	2.61e-06	2.41e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—INS—atherosclerosis	2.61e-06	2.41e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—LPL—atherosclerosis	2.59e-06	2.39e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—LPL—atherosclerosis	2.57e-06	2.37e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—SCARB1—atherosclerosis	2.56e-06	2.37e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—MTHFR—atherosclerosis	2.54e-06	2.34e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—GPX1—atherosclerosis	2.53e-06	2.34e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—GPX1—atherosclerosis	2.51e-06	2.32e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—PPARA—atherosclerosis	2.49e-06	2.3e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—MTHFR—atherosclerosis	2.47e-06	2.29e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—CD36—atherosclerosis	2.46e-06	2.28e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—ALB—atherosclerosis	2.45e-06	2.26e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—CD36—atherosclerosis	2.44e-06	2.26e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—PPARA—atherosclerosis	2.43e-06	2.24e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—HMGCR—atherosclerosis	2.42e-06	2.24e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—AGT—atherosclerosis	2.41e-06	2.23e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—HMOX1—atherosclerosis	2.4e-06	2.22e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—ALB—atherosclerosis	2.39e-06	2.21e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—PIK3CG—atherosclerosis	2.39e-06	2.21e-05	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—AKT1—atherosclerosis	2.38e-06	2.2e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—APOE—atherosclerosis	2.36e-06	2.18e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—AGT—atherosclerosis	2.35e-06	2.17e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—NOS3—atherosclerosis	2.34e-06	2.16e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—CAV1—atherosclerosis	2.34e-06	2.16e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—APOA1—atherosclerosis	2.33e-06	2.16e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—MTHFR—atherosclerosis	2.33e-06	2.16e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—MTHFR—atherosclerosis	2.31e-06	2.14e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—APOE—atherosclerosis	2.3e-06	2.13e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—PPARG—atherosclerosis	2.3e-06	2.13e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—APOB—atherosclerosis	2.3e-06	2.12e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—PPARA—atherosclerosis	2.29e-06	2.12e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—NOS3—atherosclerosis	2.29e-06	2.11e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—CAV1—atherosclerosis	2.28e-06	2.11e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—APOA1—atherosclerosis	2.28e-06	2.11e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—PPARA—atherosclerosis	2.27e-06	2.1e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—INS—atherosclerosis	2.26e-06	2.09e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—GSTM1—atherosclerosis	2.24e-06	2.07e-05	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—AKT1—atherosclerosis	2.22e-06	2.05e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—AGT—atherosclerosis	2.22e-06	2.05e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—AGT—atherosclerosis	2.2e-06	2.03e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—LPL—atherosclerosis	2.19e-06	2.03e-05	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—AKT1—atherosclerosis	2.19e-06	2.02e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—APOE—atherosclerosis	2.17e-06	2.01e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—IL6—atherosclerosis	2.16e-06	2e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—ABCA1—atherosclerosis	2.16e-06	2e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—APOE—atherosclerosis	2.15e-06	1.99e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—CAV1—atherosclerosis	2.15e-06	1.99e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—APOA1—atherosclerosis	2.15e-06	1.98e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—GPX1—atherosclerosis	2.14e-06	1.98e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—PTGS2—atherosclerosis	2.14e-06	1.98e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—CAV1—atherosclerosis	2.13e-06	1.97e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—PIK3CG—atherosclerosis	2.13e-06	1.97e-05	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—AKT1—atherosclerosis	2.13e-06	1.97e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—APOA1—atherosclerosis	2.13e-06	1.97e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—PTGS2—atherosclerosis	2.09e-06	1.93e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—CD36—atherosclerosis	2.08e-06	1.93e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—PIK3CG—atherosclerosis	2.08e-06	1.92e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—ALB—atherosclerosis	2.07e-06	1.92e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—PPARG—atherosclerosis	2.06e-06	1.9e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—INS—atherosclerosis	2.02e-06	1.86e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—PPARG—atherosclerosis	2.01e-06	1.86e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—AKT1—atherosclerosis	1.99e-06	1.84e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—NOS3—atherosclerosis	1.98e-06	1.83e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—MTHFR—atherosclerosis	1.98e-06	1.83e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—INS—atherosclerosis	1.97e-06	1.82e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—PIK3CG—atherosclerosis	1.96e-06	1.81e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—PIK3CG—atherosclerosis	1.94e-06	1.8e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—PPARA—atherosclerosis	1.94e-06	1.79e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—PPARG—atherosclerosis	1.89e-06	1.75e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—AGT—atherosclerosis	1.88e-06	1.74e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—PPARG—atherosclerosis	1.87e-06	1.73e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—INS—atherosclerosis	1.85e-06	1.71e-05	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—AKT1—atherosclerosis	1.85e-06	1.71e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—HMOX1—atherosclerosis	1.85e-06	1.71e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—ALB—atherosclerosis	1.85e-06	1.71e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—APOE—atherosclerosis	1.84e-06	1.7e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—INS—atherosclerosis	1.84e-06	1.7e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—CAV1—atherosclerosis	1.82e-06	1.68e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—APOA1—atherosclerosis	1.82e-06	1.68e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—PTGS2—atherosclerosis	1.81e-06	1.68e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—ALB—atherosclerosis	1.8e-06	1.67e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—APOB—atherosclerosis	1.77e-06	1.64e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—NOS3—atherosclerosis	1.77e-06	1.64e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—NOS3—atherosclerosis	1.73e-06	1.6e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—GSTM1—atherosclerosis	1.73e-06	1.6e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—ALB—atherosclerosis	1.7e-06	1.57e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—LPL—atherosclerosis	1.69e-06	1.57e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—ALB—atherosclerosis	1.69e-06	1.56e-05	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—AKT1—atherosclerosis	1.67e-06	1.54e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—PIK3CG—atherosclerosis	1.66e-06	1.53e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—GPX1—atherosclerosis	1.65e-06	1.53e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—NOS3—atherosclerosis	1.63e-06	1.5e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—PTGS2—atherosclerosis	1.62e-06	1.5e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—NOS3—atherosclerosis	1.61e-06	1.49e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—CD36—atherosclerosis	1.61e-06	1.49e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—PPARG—atherosclerosis	1.6e-06	1.48e-05	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—AKT1—atherosclerosis	1.59e-06	1.47e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—PTGS2—atherosclerosis	1.58e-06	1.46e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—INS—atherosclerosis	1.57e-06	1.45e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—MTHFR—atherosclerosis	1.52e-06	1.41e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PPARA—atherosclerosis	1.5e-06	1.38e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—PTGS2—atherosclerosis	1.49e-06	1.38e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—PTGS2—atherosclerosis	1.47e-06	1.36e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—AKT1—atherosclerosis	1.47e-06	1.36e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—AKT1—atherosclerosis	1.45e-06	1.34e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—AGT—atherosclerosis	1.45e-06	1.34e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—ALB—atherosclerosis	1.44e-06	1.33e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—APOE—atherosclerosis	1.42e-06	1.31e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—CAV1—atherosclerosis	1.41e-06	1.3e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—APOA1—atherosclerosis	1.4e-06	1.3e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—NOS3—atherosclerosis	1.38e-06	1.27e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—AKT1—atherosclerosis	1.35e-06	1.25e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PIK3CG—atherosclerosis	1.28e-06	1.18e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—PTGS2—atherosclerosis	1.26e-06	1.17e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PPARG—atherosclerosis	1.24e-06	1.14e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—INS—atherosclerosis	1.21e-06	1.12e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—ALB—atherosclerosis	1.11e-06	1.03e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—AKT1—atherosclerosis	1.08e-06	9.95e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—NOS3—atherosclerosis	1.06e-06	9.83e-06	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—AKT1—atherosclerosis	1.05e-06	9.72e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PTGS2—atherosclerosis	9.73e-07	8.99e-06	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—AKT1—atherosclerosis	9.11e-07	8.42e-06	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—AKT1—atherosclerosis	8.13e-07	7.52e-06	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—AKT1—atherosclerosis	7.93e-07	7.34e-06	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—AKT1—atherosclerosis	7.48e-07	6.91e-06	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—AKT1—atherosclerosis	7.41e-07	6.85e-06	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—AKT1—atherosclerosis	6.33e-07	5.86e-06	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—AKT1—atherosclerosis	4.89e-07	4.52e-06	CbGpPWpGaD
